Ironwood Gears Up For Phase III China Linaclotide Trial; Eyes On South America And Other Emerging Markets

Taking an unusually global perspective for a clinical-stage biotech, Ironwood Pharmaceuticals has plans to undertake clinical trials of its lead gastrointestinal drug, linaclotide, in China, Brazil and other emerging markets, then seek regional partners.